Literature DB >> 12699010

New drugs for HIV therapy.

Roy M Gulick1, Schlomo Staszewski.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12699010     DOI: 10.1097/00002030-200216004-00019

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  3 in total

1.  Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression.

Authors:  Lucette A Cysique; Bruce J Brew
Journal:  J Neurovirol       Date:  2011-03-17       Impact factor: 2.643

2.  Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdom: multicentre cohort study.

Authors:  Caroline A Sabin; Teresa Hill; Fiona Lampe; Ryanne Matthias; Sanjay Bhagani; Richard Gilson; Mike S Youle; Margaret A Johnson; Martin Fisher; George Scullard; Philippa Easterbrook; Brian Gazzard; Andrew N Phillips
Journal:  BMJ       Date:  2005-03-04

3.  Crystallographic study of a novel subnanomolar inhibitor provides insight on the binding interactions of alkenyldiarylmethanes with human immunodeficiency virus-1 reverse transcriptase.

Authors:  Matthew D Cullen; William C Ho; Joseph D Bauman; Kalyan Das; Eddy Arnold; Tracy L Hartman; Karen M Watson; Robert W Buckheit; Christophe Pannecouque; Erik De Clercq; Mark Cushman
Journal:  J Med Chem       Date:  2009-10-22       Impact factor: 7.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.